Terms: = Bone cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
28 results:
1. Extra-mandibular Osteoradionecrosis after the treatment of Head and Neck cancer.
Kovarik PDE; Patil R; Cvek J; Kelly C; Jackson M; Mackenzie L; West N; Willis N; Kovarik JP; Banks R; Kennedy M; Adams J; Iqbal MS
Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e498-e505. PubMed ID: 37433701
[TBL] [Abstract] [Full Text] [Related]
2. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
[TBL] [Abstract] [Full Text] [Related]
3. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Bushen Hugu Decoction in the treatment of Malignant Tumor bone Metastases.
Sang T; Zhang T; Wang J; Zheng Y
Biomed Res Int; 2022; 2022():2055900. PubMed ID: 36440359
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Hattinger CM; Casotti C; Patrizio MP; Luppi S; Fantoni L; Scotlandi K; Ibrahim T; Serra M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233089
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Time to Diagnosis on Morbidity and Survival in Children With Malignant Central Nervous System Tumors.
Ronsley R; Crowell C; Irvine M; Kang M; Goldman RD; Erker C; Cheng S
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e188-e193. PubMed ID: 35129148
[TBL] [Abstract] [Full Text] [Related]
6. Achieving a timely diagnosis for teenagers and young adults with cancer: the ACE "too young to get cancer?" study.
Dommett RM; Pring H; Cargill J; Beynon P; Cameron A; Cox R; Nechowska A; Wint A; Stevens MCG
BMC Cancer; 2019 Jun; 19(1):616. PubMed ID: 31234813
[TBL] [Abstract] [Full Text] [Related]
7. Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Hattinger CM; Biason P; Iacoboni E; Gagno S; Fanelli M; Tavanti E; Vella S; Ferrari S; Roli A; Roncato R; Giodini L; Scotlandi K; Picci P; Toffoli G; Serra M
Oncotarget; 2016 Sep; 7(38):61970-61987. PubMed ID: 27566557
[TBL] [Abstract] [Full Text] [Related]
8. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract] [Full Text] [Related]
9. Alternatives to surgical approach for giant spinal schwannomas.
Onen MR; Simsek M; Naderi S
Neurosciences (Riyadh); 2016 Jan; 21(1):30-6. PubMed ID: 26818164
[TBL] [Abstract] [Full Text] [Related]
10. Investigation of ERCC1 and ercc2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
Zhang Q; Lv LY; Li BJ; Zhang J; Wei F
Genet Mol Res; 2015 Sep; 14(3):11235-41. PubMed ID: 26400354
[TBL] [Abstract] [Full Text] [Related]
11. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
Ji WP; He NB
Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
[TBL] [Abstract] [Full Text] [Related]
12. Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients.
Brasme JF; Chalumeau M; Oberlin O; Valteau-Couanet D; Gaspar N
J Clin Oncol; 2014 Jun; 32(18):1935-40. PubMed ID: 24841977
[TBL] [Abstract] [Full Text] [Related]
13. [Efficacy of albumin-bound paclitaxel in advanced gastric cancer patients].
Gong JF; Lu M; Li J; Li Y; Zhou J; Lu ZH; Wang XC; Li J; Zhang XT; Shen L
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 46(1):144-8. PubMed ID: 24535367
[TBL] [Abstract] [Full Text] [Related]
14. A systematic review of time to diagnosis in children and young adults with cancer.
Lethaby CD; Picton S; Kinsey SE; Phillips R; van Laar M; Feltbower RG
Arch Dis Child; 2013 May; 98(5):349-55. PubMed ID: 23476000
[TBL] [Abstract] [Full Text] [Related]
15. Association of four ERCC1 and ercc2 SNPs with survival of bone tumour patients.
Hao T; Feng W; Zhang J; Sun YJ; Wang G
Asian Pac J Cancer Prev; 2012; 13(8):3821-4. PubMed ID: 23098477
[TBL] [Abstract] [Full Text] [Related]
16. Identification of distinct phenotypes of locally advanced pancreatic adenocarcinoma.
Teo M; Crotty GF; O'Súilleabháin C; Ridgway PF; Conlon KC; Power DG; McDermott RS
J Gastrointest Cancer; 2013 Mar; 44(1):73-8. PubMed ID: 22829058
[TBL] [Abstract] [Full Text] [Related]
17. Effect of art making on cancer-related symptoms of blood and marrow transplantation recipients.
Lawson LM; Williams P; Glennon C; Carithers K; Schnabel E; Andrejack A; Wright N
Oncol Nurs Forum; 2012 Jul; 39(4):E353-60. PubMed ID: 22750906
[TBL] [Abstract] [Full Text] [Related]
18. Patient perceptions of an art-making experience in an outpatient blood and marrow transplant clinic.
Mische Lawson L; Glennon C; Amos M; Newberry T; Pearce J; Salzman S; Young J
Eur J Cancer Care (Engl); 2012 May; 21(3):403-11. PubMed ID: 22150782
[TBL] [Abstract] [Full Text] [Related]
19. Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline xpd and XRCC3 homozygous polymorphisms.
Diamond HR; Ornellas MH; Orfao A; Gomes BE; Campos MM; Fernandez TS; da Silva RI; Alves G; Lage C; da Silva DA; Moellmann-Coelho A; da Cruz GS; Bouzas LF; Abdelhay E
J Hematol Oncol; 2011 Sep; 4():39. PubMed ID: 21951951
[TBL] [Abstract] [Full Text] [Related]
20. Common variations in ercc2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract] [Full Text] [Related]
[Next]
